Vineet LaboratoriesNSE:VINEETLAB +0.18%38 Gross Margin % is 37.50% as of Dec. 2025, which is 123% above its 10-year median of 16.84. GuruFocus rates NSE:VINEETLAB with a GF Score™ of 38/100 and a GF Value™ of ₹15.48 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,561 Chemicals companies, Vineet Laboratories ranks worse than 80.65% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Vineet Laboratories had a gross margin of 37.50% for the quarter that ended in Dec. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Vineet Laboratories Gross Margin % Related Terms
Vineet Laboratories Gross Margin % Historical Data
* Premium members only.
The historical data trend for Vineet Laboratories's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Vineet Laboratories's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vineet Laboratories Gross Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Vineet Laboratories's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Vineet Laboratories's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Vineet Laboratories (NSE:VINEETLAB) has a Gross Margin % of 37.50% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Vineet Laboratories and its competitors. This is 123% above median its historical median of 16.84. Over the past decade, Vineet Laboratories' Gross Margin % has ranged from 4.11 to 22.38. According to the industry distribution chart, Vineet Laboratories ranks #1259 out of 1561 companies in the Chemicals industry, placing it in the top 80.7%.
Is Vineet Laboratories' Gross Margin % too high?
Vineet Laboratories' current Gross Margin % of 37.50% is 123% above median its 10-year median of 16.84. Over the past 10 years, this metric has ranged from a low of 4.11 to a high of 22.38. The Chemicals industry median Gross Margin % is 23.35. Vineet Laboratories' value of 37.50% is 60.6% above this industry median. Based on the distribution chart, Vineet Laboratories ranks #1259 out of 1561 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Vineet Laboratories has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vineet Laboratories' Gross Margin % compare to DOW?
According to the Chemicals industry distribution chart, Vineet Laboratories ranks #1259 out of 1561 companies for Gross Margin %. This places Vineet Laboratories in the lower half of its industry. The industry median Gross Margin % is 23.35. Vineet Laboratories' value of 37.50% is 60.6% above this benchmark. Historically, Vineet Laboratories' own Gross Margin % has ranged from 4.11 to 22.38 over the past decade. While the company's 10-year median is 16.84 vs. the industry median of 23.35, Vineet Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Chemicals company?
The median Gross Margin % among Chemicals companies is 23.35, based on 1,561 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vineet Laboratories's current Gross Margin % of 37.50% is 60.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Vineet Laboratories and its competitors. For the Chemicals industry, the median Gross Margin % is 23.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vineet Laboratories's current Gross Margin % is 37.50%, which is 123% above median its own 10-year median of 16.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vineet Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vineet Laboratories (NSE:VINEETLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹15.48, compared to a current price of ₹34.00 — trading 119.6% above its estimated fair value. The current Gross Margin % is 37.50%, which is 123% above median its 10-year median of 16.84 and 60.6% above the Chemicals industry median of 23.35. Vineet Laboratories' overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Vineet Laboratories (NSE:VINEETLAB), the current Gross Margin % is 37.50% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vineet Laboratories (NSE:VINEETLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued.
The current stock price of ₹34.00 is trading 119.6% above its estimated GF Value™ of ₹15.48.
GuruFocus considers Vineet Laboratories to be Significantly Overvalued.
Key valuation signals for NSE:VINEETLAB:
Gross Margin %: 37.50% (123% above median its 10-year median of 16.84)
GF Value™: ₹15.48 vs. price of ₹34.00 (119.6% above fair value)
Industry Position: 60.6% above the Chemicals median (#1259 of 1561)
No single metric tells the full story. See the NSE:VINEETLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
38GF Score
Get the complete analysis for NSE:VINEETLAB
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VINEETLAB has been successfully added to your 
